Enzimologia Diagnóstica

Authors

  • Cesar Lima Santos Instituto Nacional de Câncer (INCA). Rio de Janeiro (RJ), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.1964v20n27.3742

Keywords:

Pancreatic Neoplasms diagnosis, Enzymes/analysis, Enzyme Stability, 3-Hydroxysteroid Dehydrogenases

Abstract

The A. makes a resumé of the presente status of'knowledge concerning the nature. origin and biological fate of enzymes. Methods of isolation of organ-speciíic enzymes and their potentialities in the diagnosis of tissue lesions are anlysed. Selective criteria of enzyme studies for diagnostic purposes are discussed. Serum lactic dehydrogenase and serum isocitric dehydrogenase, two of the so-called “metabolic” enzymes, are related in basic patterns of activity in several diaseases. Enzyme activities in myocardial infarction are discribed ande discussed, with particular emphasis on Hidroxibutiric dehydrogenase. An analysis of the compared activities of Glutamic oxaloacetic transaminase and Lactic de hydrogenase in pulmonary infarction is presented. Diagnostic and prognostic aspects of aldolase determinations in progressive muscular distrophy are discussed. A tabulation is made of enzyme activities in câncer diseases. The A. takes up the results of research of BODANSKY and cols. on Phosprohexose Isomerase and Aldolase in prognostic evaluation of mammary and prostatic câncer. A review is made on the importance of Acid and Alkaline phosphatase activities in primary and metastatic bone tumors and Ca. of the prostate. Particular mention is made of an outstanding paper by WETSTONE and cols. in which these auhors call attention to the low leveis of serum Cholinesterase in early diagnosis of cancer. The A. makes a critic review of enzyme activities in hepatitis, Laennec’s cirrhosis and the use of these tests in the differential diagnosis of intra-hepatic and post-hepatic jaundice. The last section of the paper deals with enzyme studies in hereditary diseases caused by primary disturbances of enzyme control. The A. calls attention to the recently divised “Dibucaine Number test to detect congenital abnormalities of Cholinesterase activity. Since a clear-cut clinicai picure does not occur in these patients, their detection is extremely important. When exposed to Cholinesterase inhibitors they go into prolonged respiratory arrest which may be fatal. The A. advocates the inclusion of the “Dibucaine Number” test as a routine procedure on admission of I.N.C. patients in order to avoid the catastrophic results of some of the often-used Cholinesterase inhibitors.

Downloads

Download data is not yet available.

References

AGREN, G., e LAGERLOF, H. O., Acta Med. Scand., 32, 359, 1937. DOI: https://doi.org/10.1111/j.0954-6820.1937.tb09956.x

AGRESS, C. M., Evaluation of the Transaminase Test., Am. J. Cardiol., 3: 74-93, 1959. DOI: https://doi.org/10.1016/0002-9149(59)90398-4

BODANSKY, O., Enzymes in Tumor Growth, in “Enzymes in Health and Disease”, Charles C. Thomas — 1960 Ed.

BODANSKY, O., Diagnostic Applications of Enzymes in Medicine. Am. J. Med. '861-874, N.° 6, Dec. 1959. DOI: https://doi.org/10.1016/0002-9343(59)90172-X

BROWN, M. E., New England L Med. 260, 331, 1959. DOI: https://doi.org/10.1056/NEJM195902122600707

BURTON, P. EVANS, D. G., HARPER, A. A., etc., Gut., 1, 111 e 1, 125. DOI: https://doi.org/10.1136/gut.1.2.111

COOKE, K. B., e ZILVA, J. F., J. Clin. Path., 14, 500, 1961. DOI: https://doi.org/10.1136/jcp.14.5.500

DIXON, T. F. e PURDOM, M., J. Clin. Path., 7, 341, 1954. DOI: https://doi.org/10.1136/jcp.7.4.341

DREYFUS, J. C., SCHAPIRA, G., e SCHAPIRA, F., Ann. N. Y. Acad. Sci. 75, 235, 1958. DOI: https://doi.org/10.1111/j.1749-6632.1958.tb36870.x

DUNCAN, P. R., HARPER, A. A., HOWAT, H. T., OLEESKY, S. e VARLEY, H., J. Physiol., 111, 63 P., 1950.

ELLIOTT, B. A., e WILKINSON, J. H., Lancet, i, 698, 1961. DOI: https://doi.org/10.1016/S0140-6736(61)91724-X

EISHMAN, W. H., BONNER, C. D., HOMBURGER, E., New England J. Med., 255, 925, 1956. DOI: https://doi.org/10.1056/NEJM195611152552001

GUTMAN, A. B., Amer. J. Med. 27, 875, 1959. DOI: https://doi.org/10.1016/0002-9343(59)90173-1

HARRIS, H., WHITTAKER, M., LEHMANN, H., e SILK, E., Acta genet., 10, 1, 1960. DOI: https://doi.org/10.1159/000151112

HUNT, A. H., e LEHMAN, H., J. Clin. Path., 12, 583, 1959.

KALOW, W., Biochemistry of Human Genetics. Giba Found. Symp. Ed. Churchill — London — pag. 39.

KAUEMAN, K., Ann. intern. Med., 41, 553, 1954. DOI: https://doi.org/10.7326/0003-4819-41-3-553

KEIDING, N. R., Scand. J. Clin. Lab. Invest. 11, 106, 1959. DOI: https://doi.org/10.3109/00365515909060415

LA DUE, J. S., KARMEN, A., WRÓBLEWSKI, F. Science, 120, 497, 1954. DOI: https://doi.org/10.1126/science.120.3117.497

LA MOTTA, R. V., WILLIAMS, H. M., WETSTONE, H. J., Gastroenterology, 33, 50, 1957. DOI: https://doi.org/10.1016/S0016-5085(19)35788-9

LATNER, A., SMITH, A. J., Lancet. ii, 195, 1958.

MOSS, D. W., CAMPBELL, D. M. ANAGNOSTOU-KAKARAS, E., KING, E. J., Biochem. J., 81, 441, 1961. DOI: https://doi.org/10.1042/bj0810441

MOSS, D. W., CAMPBELL, D. M., ETC., Pure and Appl. Chem. 3, 397, 1961. DOI: https://doi.org/10.1351/pac196103030397

NARDI, G. L., J. Lab. Clin. Med., 52, 66, 1958.

NISSELBAUM, J. S., BODANSKY, O., J. Biol. Chem., 234, 3.276, 1959. DOI: https://doi.org/10.1016/S0021-9258(18)69664-4

NISSELBAUM, J. S., BODANSKY, O., J. Biol. Chem., 236, 401, 1961. DOI: https://doi.org/10.1016/S0021-9258(18)64375-3

OKUMURA, M., e SPELLBERG, M. A., Gastroenterology, 39, 305, 1960. DOI: https://doi.org/10.1016/S0016-5085(19)35265-5

PLAGEMANN, P. P. W., GREGORY, K. F., e WRÓBLEWSKI, F. J., Biol. Chem. 235, 2.282, 1960. DOI: https://doi.org/10.1016/S0021-9258(18)64613-7

POPPER, H., e SCHAFFNER, F., in “Liver, Structure an Fruction”, Ed. McGraw Hill. N. York, 1957.

REICHARD, H., J. Lab. Clin. Med., 57, 78, 1961.

REIS, J. L., Bull. Soc. Chem. Biol. 16, 385, 1934.

ROBERTS, W. M., Brit. Med. J., i, 734, 1933. DOI: https://doi.org/10.1136/bmj.1.3773.734

ROSALKI, S. B., e WILKINSON J. H., Nature, 188, 1.110, 1960. DOI: https://doi.org/10.1038/188110a0

ROSEMBERG, 1. N., J. Clin. Invest. 38, 630, 1959. DOI: https://doi.org/10.1172/JCI103841

SIBLEY, J. A., LEHNINGER, A. L., J. Nat. Câncer Inst. 9, 303, 1949.

SILVERMAN, L, LIVINGSTON, S. F., Cancer, 13, 921, 1960. DOI: https://doi.org/10.1002/1097-0142(196009/10)13:5<921::AID-CNCR2820130510>3.0.CO;2-1

STRANDJORD, P. E., THOMAS, K. E., e WHITE, L. P., J. Clin. Invset. 38, 2.111, 1960.

SUN, D. C. H., e SHAY, H., Gastroenterology, 38, 570, 1960. DOI: https://doi.org/10.1016/S0016-5085(60)80030-3

VESEL, E. S., e BERN, A. G., Ann. N. Y. Acad. Sei., 75, 826, 1958.

VORHAUS, L. J. e KARK, R. M., Amer. J. Med., 14, 707, 1953. DOI: https://doi.org/10.1016/0002-9343(53)90390-8

YOUNG, I. L, Ann. N. Y. Acad. Sci., 75, 357, 1958. DOI: https://doi.org/10.1111/j.1749-6632.1958.tb36883.x

WETSTONE, H. J., LA MOTTA, R. V., BELLUCCI, A., TENNANT, R., e WHITE, B. B., Ann. Intern. Med.., 52, 102, 1960. DOI: https://doi.org/10.7326/0003-4819-52-1-102

WHITE. L. P., Advances in die Diagnostic Use of Enzymes — in “Enzymes in Health and Disease”. Charles C. Thomas — 1960.

WILKINSON, J. H., An Introduction to Diagnostic Enzymology — Ed. Arnold. 1962.

WRÓBLEWSKI, F., e LA DUE, J. S., Proc. Soc. exp. Biol. N. Y. 90, 210, 1955. DOI: https://doi.org/10.3181/00379727-90-21985

MACLAGAN, N. F., Differential Diagnosis of Jaundice, Brit. Med. Jour. 2, 197, 1947. DOI: https://doi.org/10.1136/bmj.2.4518.197

Published

2023-09-01

How to Cite

1.
Santos CL. Enzimologia Diagnóstica. Rev. Bras. Cancerol. [Internet]. 2023 Sep. 1 [cited 2024 Nov. 22];20(27):23-64. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3742

Issue

Section

ORIGINAL ARTICLE